1. Home
  2. ABUS vs NAT Comparison

ABUS vs NAT Comparison

Compare ABUS & NAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABUS
  • NAT
  • Stock Information
  • Founded
  • ABUS N/A
  • NAT 1995
  • Country
  • ABUS United States
  • NAT Bermuda
  • Employees
  • ABUS N/A
  • NAT N/A
  • Industry
  • ABUS Biotechnology: Pharmaceutical Preparations
  • NAT Marine Transportation
  • Sector
  • ABUS Health Care
  • NAT Consumer Discretionary
  • Exchange
  • ABUS Nasdaq
  • NAT Nasdaq
  • Market Cap
  • ABUS 617.3M
  • NAT 534.5M
  • IPO Year
  • ABUS N/A
  • NAT 1997
  • Fundamental
  • Price
  • ABUS $3.51
  • NAT $2.44
  • Analyst Decision
  • ABUS Strong Buy
  • NAT Hold
  • Analyst Count
  • ABUS 4
  • NAT 2
  • Target Price
  • ABUS $5.50
  • NAT $3.50
  • AVG Volume (30 Days)
  • ABUS 1.0M
  • NAT 2.8M
  • Earning Date
  • ABUS 03-27-2025
  • NAT 02-28-2025
  • Dividend Yield
  • ABUS N/A
  • NAT 13.93%
  • EPS Growth
  • ABUS N/A
  • NAT N/A
  • EPS
  • ABUS N/A
  • NAT 0.22
  • Revenue
  • ABUS $6,171,000.00
  • NAT $225,096,000.00
  • Revenue This Year
  • ABUS N/A
  • NAT $21.35
  • Revenue Next Year
  • ABUS $61.99
  • NAT $4.61
  • P/E Ratio
  • ABUS N/A
  • NAT $11.12
  • Revenue Growth
  • ABUS N/A
  • NAT N/A
  • 52 Week Low
  • ABUS $2.30
  • NAT $2.39
  • 52 Week High
  • ABUS $4.72
  • NAT $4.40
  • Technical
  • Relative Strength Index (RSI)
  • ABUS 58.89
  • NAT 39.93
  • Support Level
  • ABUS $3.20
  • NAT $2.44
  • Resistance Level
  • ABUS $3.45
  • NAT $2.52
  • Average True Range (ATR)
  • ABUS 0.14
  • NAT 0.07
  • MACD
  • ABUS 0.03
  • NAT -0.01
  • Stochastic Oscillator
  • ABUS 78.65
  • NAT 8.00

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.

About NAT Nordic American Tankers Limited

Nordic American Tankers Ltd owns and operates double hull crude oil tankers. It is an international tanker company that owns double-hull Suezmax tankers. It operates vessels in the spot market or on spot market-related charters pursuant to cooperative arrangements with third parties. The company's fleet consists of crude oil tankers, and all of its vessels are employed in the spot market. The company has only one type of vessel - Suezmax crude oil tankers. It operates in markets that are very competitive and based mainly on supply and demand.

Share on Social Networks: